Physician

Albert B Ross, MD

According to 2025 Medicare claims, Albert Ross, MD (NPI: 1568411510) practices gastroenterology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is TROY GASTROENTEROLOGY, PC (NPI: 1699880591; TIN: 383023927) and primary practice location at 48823-7396. Ross is affiliated with the POM ACO (ACO ID: A1297) and Senior Health Connect ACO 9 (ACO ID: A5387), participating under the MSSP model.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 332 traditional Medicare patients, billed 2,903 HCPCS/CPT codes, and received $103,561 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,355 prescription claims across 743 beneficiaries totaling $2,763,878 in drug costs, led by Stelara (Ustekinumab). 2023 DME data shows 12 claims. Open Payments data shows 83 records totaling $1,948. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,523,004 and ending at $2,763,878. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	872	1,991	$204,317
2016	769	2,297	$199,155
2017	790	2,185	$192,645
2018	870	2,217	$190,628
2019	787	8,874	$247,810
2020	512	8,438	$213,132
2021	415	9,580	$233,982
2022	362	5,681	$155,981
2023	373	4,301	$134,469
2024	332	2,903	$103,561

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	618	1,945	$1,523,004
2016	606	1,639	$1,097,805
2017	663	1,854	$1,115,864
2018	667	1,658	$1,645,274
2019	696	1,606	$1,148,505
2020	651	1,720	$983,302
2021	532	1,487	$1,241,096
2022	644	1,557	$1,209,624
2023	754	1,476	$2,345,754
2024	743	1,355	$2,763,878

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$2,176
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	109	109	$195
43248	Insertion of guide wire with dilation of esophagus using a flexible endoscope	39	46	$105
45380	Biopsy of large bowel using a flexible endoscope	39	39	$89
43235	Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope	31	31	$70
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	58	61	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	46	2,212	$1,288,477
Humira(Cf) Pen	Adalimumab	50	1,400	$481,232
Skyrizi On-Body	Risankizumab-Rzaa	17	952	$352,753
Inflectra	Infliximab-Dyyb	11	436	$82,049
Creon	Lipase/Protease/Amylase	14	383	$45,279

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$1,948	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert B. Ross, MD?

Tedicare shows public-source Medicare data for Albert B. Ross, MD (NPI 1568411510), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert B. Ross, MD have ACO affiliation data?

Albert B. Ross, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Senior Health Connect ACO 9 (MSSP, ACO ID A5387).

What billing organization is linked to Albert B. Ross, MD?

Albert B. Ross, MD is linked to TROY GASTROENTEROLOGY, PC (billing NPI 1699880591) in the available physician profile data.

Does Albert B. Ross, MD have Open Payments data?

Albert B. Ross, MD has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.